1. Orazi A, Bennett JM, Germing U et al (2017) Myelodysplastic/myeloproliferative neoplasms. In: Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of tumors of haematopoietic and lymphoid tissues. IARC, Lyon (Chapter 5)
2. Neukirchen J, Schoonen WM, Strupp C, Gattermann N, Aul C, Haas R, Germing U (2011) Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry. Leuk Res 35(12):1591–1596
3. Zoi K, Cross NC (2015) Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable. Int J Hematol 101(3):229–242
4. Schuler E, Schroeder M, Neukirchen J, Strupp C, Xicoy B, Kündgen A, Hildebrandt B, Haas R, Gattermann N, Germing U (2014) Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias. Leuk Res 38(12):1413–1419
5. Germing U, Blum S, Boch T, Lübbert M, Metzgeroth G, Platzbecker U, Pfeilstöcker M Onkopedia Leitlinie Chronische myelomonozytäre Leukämie Stand 04/2020. https://www.onkopedia.com/de/onkopedia/guidelines/chronische-myelomonozytaere-leukaemie-cmml/@@guideline/html/index.html. Zugegriffen: 03.12.2020